Cite
HARVARD Citation
Chi, S. et al. (n.d.). EPCT-09. ROVER: A phase 1/2 study of avapritinib in pediatric patients with solid tumors dependent on KIT or PDGFRA signaling. Neuro-oncology. pp. i37-i38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chi, S. et al. (n.d.). EPCT-09. ROVER: A phase 1/2 study of avapritinib in pediatric patients with solid tumors dependent on KIT or PDGFRA signaling. Neuro-oncology. pp. i37-i38. [Online].